We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+2.26%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$3.43B
AUM Growth
-$3.53B
Cap. Flow
-$6.14B
Cap. Flow %
-178.75%
Top 10 Hldgs %
20.05%
Holding
4,637
New
1,031
Increased
432
Reduced
2,408
Closed
565

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Financials 5.08%
3 Healthcare 4.17%
4 Consumer Discretionary 3.04%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MATW icon
2951
Matthews International
MATW
$880M
$4.1K ﹤0.01%
157
-141
-47% -$3.46K
FLCH icon
2952
Franklin FTSE China ETF
FLCH
$307M
$4.09K ﹤0.01%
+172
New +$4.28K
WEST icon
2953
Westrock Coffee
WEST
$779M
$4.08K ﹤0.01%
1,003
-933
-48% -$4.08K
BTSG icon
2954
BrightSpring Health Services
BTSG
$12.4B
$4.08K ﹤0.01%
109
-297
-73% -$9.96K
CHAT icon
2955
Roundhill Generative AI & Technology ETF
CHAT
$1.94B
$4.07K ﹤0.01%
+69
New +$4.28K
KALV
2956
DELISTED
KalVista Pharmaceuticals
KALV
$4.04K ﹤0.01%
250
-721
-74% -$9.55K
MLR icon
2957
Miller Industries
MLR
$579M
$4.04K ﹤0.01%
108
-99
-48% -$3.85K
INGM
2958
Ingram Micro Holding
INGM
$6.74B
$4.03K ﹤0.01%
189
-989
-84% -$21.5K
SLP icon
2959
Simulations Plus
SLP
$371M
$4.03K ﹤0.01%
221
-111
-33% -$1.95K
TGTX icon
2960
TG Therapeutics
TGTX
$7.46B
$4.03K ﹤0.01%
+135
New +$4.41K
FLYW icon
2961
Flywire
FLYW
$2.13B
$4.02K ﹤0.01%
284
-3,877
-93% -$53.1K
TVTX icon
2962
Travere Therapeutics
TVTX
$5.21B
$4.01K ﹤0.01%
105
-1,448
-93% -$47.1K
XRPZ
2963
Franklin XRP ETF
XRPZ
$167M
$4.01K ﹤0.01%
+201
New +$4.38K
KBH icon
2964
KB Home
KBH
$3.56B
$4.01K ﹤0.01%
71
-920
-93% -$56.6K
SPNT icon
2965
SiriusPoint
SPNT
$2.78B
$4.01K ﹤0.01%
183
-771
-81% -$15.5K
FCG icon
2966
First Trust Natural Gas ETF
FCG
$628M
$4K ﹤0.01%
+171
New +$4K
TRC icon
2967
Tejon Ranch
TRC
$451M
$3.96K ﹤0.01%
251
-1,029
-80% -$16.4K
MLYS icon
2968
Mineralys Therapeutics
MLYS
$2.34B
$3.96K ﹤0.01%
109
-161
-60% -$6.46K
NVMI
2969
Nova
NVMI
$13.2B
$3.94K ﹤0.01%
12
TFLO icon
2970
iShares Treasury Floating Rate Bond ETF
TFLO
$6.64B
$3.94K ﹤0.01%
+78
New +$3.94K
EXP icon
2971
Eagle Materials
EXP
$6.63B
$3.93K ﹤0.01%
19
-115
-86% -$25.4K
DFIN icon
2972
Donnelley Financial Solutions
DFIN
$1.22B
$3.92K ﹤0.01%
84
+1
+1% +$48
SWX icon
2973
Southwest Gas
SWX
$6.44B
$3.92K ﹤0.01%
49
-7,769
-99% -$622K
WTI icon
2974
W&T Offshore
WTI
$509M
$3.91K ﹤0.01%
2,401
-11,015
-82% -$21.2K
SNX icon
2975
TD Synnex
SNX
$21.1B
$3.91K ﹤0.01%
26
-281
-92% -$43.1K

Similar funds

Arax Advisory Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Arax Advisory Partners held 4,637 positions worth $3.43B, down 51% from $6.97B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners withdrew a net $6.14B in Q4 2025, closing 565 positions and reducing 2,408 holdings. Its most notable exit was State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF, an estimated $39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Arax Advisory Partners opened a new position in Vanguard Morningstar Growth ETF worth $122M.

  • Arax Advisory Partners's largest Q4 2025 buy was Vanguard Morningstar Growth ETF: 1,504,890 shares worth $122M.
  • Arax Advisory Partners added most to Vanguard Total International Stock ETF in Q4 2025, an estimated $13M increase.
  • Arax Advisory Partners's biggest Q4 2025 reduction was iShares S&P 100 ETF, cutting an estimated $2.6B.
  • Arax Advisory Partners fully exited State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF in Q4 2025, selling an estimated $39M.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.43B portfolio in Q4 2025.
  • Arax Advisory Partners opened 1,031 new positions and closed 565 in Q4 2025.
  • Arax Advisory Partners's portfolio value fell 51% quarter-over-quarter to $3.43B.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.